PSYENCE BIOMEDICAL LTD (PBMWW) Operating cash flow 2023–2025
PSYENCE BIOMEDICAL LTD (PBMWW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.7MFY2025 · since FY2023: -$1.6M → -$3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.7M | -26.8% |
| FY2024 | -$2.9M | -85.0% |
| FY2023 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PBMWW financial trends
PBMWW RevenuePBMWW Net incomePBMWW Net marginPBMWW Gross profitPBMWW Gross marginPBMWW Operating incomePBMWW Operating marginPBMWW Free cash flowPBMWW Capital expendituresPBMWW Return on equityPBMWW Stock buybacksPBMWW Dividends paidPBMWW Total assetsPBMWW Total liabilitiesPBMWW Shareholders’ equityPBMWW overview →